Small-molecule inhibitors of several intracellular signaling proteins, mostly protein kinases, show tremendous selectivity and potency. The complexity and redundancy of signaling pathways presents opportunities for therapeutic selectivity and some clinical results are remarkable. New strategies are being developed to interfere with previously intractable targets, such as protein-protein interactions.
机构:
Novartis Inst Biomed Res, Dept Global Discovery Chem, Cambridge, MA 02139 USANovartis Inst Biomed Res, Dept Global Discovery Chem, Cambridge, MA 02139 USA
Peukert, Stefan
Miller-Moslin, Karen
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Inst Biomed Res, Dept Global Discovery Chem, Cambridge, MA 02139 USANovartis Inst Biomed Res, Dept Global Discovery Chem, Cambridge, MA 02139 USA
机构:
Dong A Univ, Dept Internal Med, Coll Med, Div Rheumatol, 26 Daeshingongwon Ro, Busan 49201, South KoreaDong A Univ, Dept Internal Med, Coll Med, Div Rheumatol, 26 Daeshingongwon Ro, Busan 49201, South Korea